Related Experiment Video
Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
[Hypertension and the heart]
Kristian Wachtell1, Niels Holmark Andersen, Tage Lysbo Svendsen
1Rigshospitalet, Hjertecenteret, Hjertemedicinsk Klinik B, København Ø. kristian@wachtell.dk
Insights
Treating left ventricular hypertrophy with angiotensin II receptor blockers significantly reduces cardiovascular risk. Lowering blood pressure, especially in patients with hypertension or atrial fibrillation, is crucial for preventing heart failure and improving outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiac Electrophysiology
Context:
- Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular events.
- Hypertension is a primary driver of LVH and heart failure.
- Atrial fibrillation is increasingly recognized as cardiac target organ damage.
Purpose:
- To review the prognostic importance of LVH as cardiac target organ damage.
- To highlight the efficacy of angiotensin II receptor blockade in reducing LVH.
- To emphasize the benefits of blood pressure reduction in preventing heart failure and managing atrial fibrillation.
Summary:
- Angiotensin II receptor blockers are highly effective in reducing left ventricular mass, leading to decreased cardiovascular morbidity and mortality.
- Blood pressure reduction, particularly in hypertensive individuals, significantly lowers the incidence of heart failure.
- Atrial fibrillation management should incorporate blood pressure control (targeting <130/85 mmHg) and risk factor reduction, utilizing ACE inhibitors or ARBs.
Impact:
- Effective management of LVH and hypertension can substantially reduce cardiovascular mortality.
- Integrating atrial fibrillation as target organ damage necessitates guideline revisions for blood pressure management.
- Optimizing hemodynamic status through targeted therapies like ACE inhibitors or ARBs improves patient prognosis.
Abstract:
Within the latest ten years research in left ventricular hypertrophy as cardiac target organ damage has uncovered its prognostic importance, and studies indicate that treatment with angiotensin II receptor blockade is most effective in reducing left ventricular hypertrophy. In addition, reduction of left ventricular mass is associated with substantial and significant reduction of cardiovascular morbidity and mortality. Hypertension is strongly associated with increased risk of subsequent heart failure. Meta analysis data suggests that reduction in blood pressure is also associated with very substantial reductions in incident heart failure. In addition, the authors suggest that atrial fibrillation should be considered target organ damage with the resulting implications in terms of blood pressure reduction in guidelines, and that modern treatment of atrial fibrillation should also include reduction of traditional cardiovascular risk factors as well as blood pressure reduction for blood pressures exceeding 130/185 mmHg. Reductions which should be achieved using angiotensin converting enzyme inhibitor or angiotensin receptor blockers in order to improve the hemodynamic status of the patient.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension V: Nursing Management
